DV
Dividend Vision

NDRA — ENDRA Life Sciences Inc

ENDRA Life Sciences Inc (NDRA)

Total return is -99.9% over the past 9.1 years, 369.3 points behind SPY at 269.4%. Its deepest 1-year drawdown was 59.9%.

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology designed to improve clinical diagnostic imaging, with initial focus on applications including non-alcoholic fatty liver disease assessment, tissue composition analysis, and vascular imaging. The company does not currently distribute dividends. This security appeals to investors seeking exposure to medical technology development rather than current income.

NDRA key facts

Asset type
Stock
Asset class
Equity
Inception date
06/30/2017
Last close
$4.47
Market cap
$5,969,361
Average volume
51800.0
Beta
-0.054
Payout ratio
0.0
Forward P/E
0.0
EPS
$-8.16